Evidence map›Paper›PMID 41649053›Full record

ArticleFEBS open bio2026

Differential regulation of ZFAS1 splice variants by endoplasmic reticulum stress in hepatocyte cell lines.

Sébastien Soubeyrand, Paulina Lau, Ruth McPherson

Abstract read
In one paragraph

Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sébastien SoubeyrandAtherogenomics Laboratory, University of Ottawa Heart Institute, Canada.ORCID https://orcid.org/0000-0002-9317-301X
Paulina LauAtherogenomics Laboratory, University of Ottawa Heart Institute, Canada.
Ruth McPhersonAtherogenomics Laboratory, University of Ottawa Heart Institute, Canada.

Funding

CIHR FDN-154308
6 · The paper itself

Abstract

The suppression of the long noncoding RNA (lncRNA) TRIBAL in hepatocytes was recently shown to affect the expression of pivotal regulators and hundreds of poorly understood or uncharacterized transcripts. The most upregulated transcript corresponded to a predicted splice variant of the lncRNA ZFAS1. Here, we characterize and investigate the role and regulation of ZFAS1 splice variants in liver cell models. New ZFAS1 splice variants were identified, all of which were enriched in the cytoplasm of HepG2 cells. TRIBAL suppression strongly upregulated a low-abundance ZFAS1 variant in hepatocytes but not in hepatoma models. However, preventing the upregulation of the ZFAS1 splice variant did not mitigate the impact of TRIBAL suppression in hepatocytes. ZFAS1 variants were rapidly but differentially increased in response to thapsigargin, which causes endoplasmic reticulum (ER) stress and activates the unfolded protein response (UPR). Inhibition of PERK, a central sensor of the UPR, had contrasting impacts on ZFAS1 variants in response to thapsigargin. Moreover, whereas the upregulation of the main ZFAS1 form was reduced by the suppression of the UPR mediators ATF4 and NFE2L2 (also known as NRF2), the other variants were not. Lastly, ZFAS1 suppression decreased cell viability both at baseline and in response to acute thapsigargin treatment. This work identifies novel ZFAS1 variants and uncovers a link between ER stress and ZFAS1 through the UPR.

Indexed as

Endoplasmic Reticulum StressHepatocytesRNA, Long NoncodingAlternative SplicingCell LineCell SurvivalHep G2 CellsHumansRNA SplicingThapsigarginUnfolded Protein ResponseRNA, Long NoncodingThapsigarginER stresshepatocytesHepG2TRIBALunfolded protein responseZFAS1

Identifiers

PMID41649053
PMCPMC13238724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.